SCHEMBL17066352

SCHEMBL17066352

Cc1cnc(N2CCN(C)CC2)nc1C

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR3A P46098 2/20 0.54
HRH4 Q9H3N8 2/20 0.54
ALDH1A1 P00352 8/20 0.54
CYP1A2 P05177 8/20 0.54
HSD17B10 Q99714 8/20 0.54
USP2 O75604 4/20 0.54
CASP1 P29466 3/20 0.49
CASP7 P55210 2/20 0.49
MAPK1 P28482 2/20 0.48
KMT2A Q03164 2/20 0.48
MEN1 O00255 1/20 0.48
CYP2D6 P10635 1/20 0.48
TSHR P16473 3/20 0.46
MAPT P10636 1/20 0.46
CYP2C9 P11712 2/20 0.45
POLB P06746 2/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
LMNA P02545 1/20 0.43
CYP3A4 P08684 1/20 0.43
KCNK2 O95069 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18005507 0.85 POLB (0.54) ALDH1A1CYP1A2HSD17B10USP2MAPK1
SCHEMBL1708343 0.85 POLB (0.58) ALDH1A1MAPK1TSHRMAPTPOLB
SCHEMBL12936278 0.82 HRH4 (0.51) HTR3AHRH4ALDH1A1CYP1A2HSD17B10
SCHEMBL15515363 0.82 HTR3A (0.51) HTR3AHRH4ALDH1A1CYP1A2HSD17B10
SCHEMBL20288319 0.82 HTR3A (0.54) HTR3AHRH4ALDH1A1CYP1A2HSD17B10
SCHEMBL21227113 0.82 HRH4 (0.51) HTR3AHRH4ALDH1A1CYP1A2HSD17B10
SCHEMBL12231715 0.81 TLR4 (0.46) HTR3AHRH4ALDH1A1CYP1A2HSD17B10
SCHEMBL14983697 0.81 POLB (0.44) HTR3AHRH4ALDH1A1CYP1A2HSD17B10
SCHEMBL17531186 0.80 KDM4E (0.54) ALDH1A1CYP1A2HSD17B10USP2MAPK1
SCHEMBL9486237 0.80 ALDH1A1 (0.54) ALDH1A1CYP1A2HSD17B10USP2CASP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250230155-A1 7,8-DIHYDRO-5H-1,6-NAPHTHYRIDINE DERIVATIVES AS POSITIVE ALLOSTERIC MODULATORS OF THE MUSCARINIC ACETYLCHOLINE RECEPTOR M4 FOR TREATING NEUROLOGICAL AND PSYCHIATRIC DISORDERS VANDERBILT UNIVERSITY 2025-07-17 US disclosed
US-9127021-B2 Hepatitis C virus inhibitors ENANTA PHARMACEUTICALS, INC. (US) 2015-09-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250230155-A1 7,8-DIHYDRO-5H-1,6-NAPHTHYRIDINE DERIVATIVES AS POSITIVE ALLOSTERIC MODULATORS OF THE MUSCARINIC ACETYLCHOLINE RECEPTOR M4 FOR TREATING NEUROLOGICAL AND PSYCHIATRIC DISORDERS CHRM5, CHRM4, CHRM1 HTR3A 83/4885HRH4 73/4885ALDH1A1 1671/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.